Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Deciphera Pharmaceuticals Inc. (DCPH)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Opaleye Management

James A. Silverman

340,000 $7,136 -20% 2.66%
2.
Redmile Group

Jeremy Green

1,653,180 $34,700 +12% 1.39%
3.
Nexthera Capital

Ori Hershkovitz

121,892 $2,559 +299% 1.05%
4.
OrbiMed Advisors

Samuel Isaly

2,442,200 $51,262 +26% 0.94%
5.
Eversept Partners

Kamran Moghtaderi

69,700 $1,463 0.8%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.00 375,000 Large Shareholder 2,146,308 2017-10-02 Filing
$17.00 375,000 Large Shareholder, Director 2,146,308 2017-10-02 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$30.00 1,500 Officer 0 2019-02-19 Filing
$28.04 17,782 Director 0 2019-02-15 Filing
$28.01 1,101 Director 0 2019-02-14 Filing
$30.00 3,997 Officer, Director 0 2019-02-19 Filing
$28.01 4,934 Officer, Director 0 2019-02-15 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 18,200 $422 0%